. 2020 Apr 10;12(2):124–130. doi: 10.4103/jpbs.JPBS_11_20
© 2020 Journal of Pharmacy and Bioallied Sciences
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Figure 3.
Stakeholders’ perception for biosimilars entry into India